摘要
目的:探讨中期妊娠引产应用米非司酮辅助利凡诺治疗疗效。方法:将各种原因需引产的中期妊娠孕妇206例随机分为两组,观察组105例,采用米非司酮辅助利凡诺引产;对照组101例,仅采用利凡诺引产。结果:观察组引产成功率98.1%,显著高于对照组87.1%(X2=9.17,P<0.01);观察组清宫率19.0%,明显低于对照组66.3%(X2=47.19,P<0.01)。观察组引产时间、产后2h出血量均较对照组有明显缩短或减少(P<0.05)。结论:米非司酮辅助利凡诺用于中期妊娠引产疗效显著,引产成功率高,值得临床应用。
Objective： To explore the clinical effects of induction of labor in midpregnancy treated by mifepristone and ethacridine.Method：206 gravida of induction of labor in midpregnancy were randomly divided into the observation group（n=105）,the control group（n=101）.The observation group were treated by mifepristone and ethacridine,and the control group were given only ethacridine.Result：The success rate of the observation group was 98.1%,significantly difference to the control group（X2=9.17,P0.01）;the rate of curettage in the observation group was 19.0%,lower obviously compared with the control group（X2=47.19,P0.01）.There were significantly difference in induced labor time and the amount of bleeding after 2 hours of odinopoeia between two groups（P0.05）.Conclusion：The clinical effects of induction of labor in midpregnancy treated by mifepristone and ethacridine would be effective,high success rate of odinopoeia,worthy of clinical apply.
出处
《河北医学》
CAS
2012年第1期45-47,共3页
Hebei Medicine
关键词
中期妊娠引产
米非司酮
利凡诺
Induction of labor in midpregnancy
Mifepristone
Ethacridine
